首页> 外国专利> USING THE ASSOCIATION OF A SINUSAL IF CURRENT INHIBITOR AND ANGIOTENSIN CONVERSION ENZYME FOR TREATMENT OF HEART FAILURE

USING THE ASSOCIATION OF A SINUSAL IF CURRENT INHIBITOR AND ANGIOTENSIN CONVERSION ENZYME FOR TREATMENT OF HEART FAILURE

机译:使用正弦电流抑制剂和血管紧张素转化酶联合治疗心力衰竭

摘要

The use of the combination of a sinus if current inhibitor and an angiotensin converting enzyme inhibitor for the treatment of heart failure The present invention relates to the combination of a selective and specific if sinus current inhibitor, most especially ivabradine or n - {[(7s) -3,4-dimethoxybicyclo [4.2.0] octa-1,3,5-trien-7-yl] methyl} -3- (7,8-dimethoxy-1,2,4 , 5-Tetrahydro-3h-3-benzazepin-3-yl) -n-methyl-3-oxo-1-propanamine and an angiotensin converting enzyme inhibiting agent for the production of insulin treatment medicinal products especially heart failure with conserved systolic function.
机译:鼻窦电流抑制剂与血管紧张素转化酶抑制剂的组合在治疗心力衰竭中的用途本发明涉及选择性和特异性鼻窦电流抑制剂,尤其是伊伐布雷定或n-{[(7s )-3,4-二甲氧基双环[4.2.0] octa-1,3,5-三烯-7-基]甲基} -3-(7,8-二甲氧基-1,2,4,5-四氢-3h- 3-苯并ze庚因-3-基)-正甲基-3-氧代-1-丙胺和血管紧张素转化酶抑制剂,用于生产胰岛素治疗药物,尤其是具有保守的收缩功能的心力衰竭。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号